Estrogens and Cerebrovascular Stroke: What Do Animal Models Teach Us?
- Published in:
- Annals of the New York Academy of Sciences, 2005, v. 1052, n. 1, p. 225, doi. 10.1196/annals.1347.017
- By:
- Publication type:
- Article
Works matching IS 00778923 AND DT 2005 AND VI 1052 AND IP 1
Results: 24
1
2
Summary.
- Published in:
- Annals of the New York Academy of Sciences, 2005, v. 1052, n. 1, p. 259, doi. 10.1196/annals.1347.027
- By:
- Publication type:
- Article
3
Impact of Metabolism on the Safety of Estrogen Therapy.
- Published in:
- Annals of the New York Academy of Sciences, 2005, v. 1052, n. 1, p. 243, doi. 10.1196/annals.1347.018
- By:
- Publication type:
- Article
4
Role of Nonfeminizing Estrogens in Brain Protection from Cerebral Ischemia: An Animal Model of Alzheimer's Disease Neuropathology.
- Published in:
- Annals of the New York Academy of Sciences, 2005, v. 1052, n. 1, p. 233, doi. 10.1196/annals.1347.019
- By:
- Publication type:
- Article
5
Estrogen Bows to a New Master: The Role of Gonadotropins in Alzheimer Pathogenesis.
- Published in:
- Annals of the New York Academy of Sciences, 2005, v. 1052, n. 1, p. 201, doi. 10.1196/annals.1347.020
- By:
- Publication type:
- Article
6
Part V: What Are Appropriate Surrogate Markers of Neurological Decline and What Experimental Models Are Best to Assess the Efficacy of Hormone/Estrogen Therapy?
- Published in:
- Annals of the New York Academy of Sciences, 2005, v. 1052, n. 1, p. 199, doi. 10.1196/annals.1347.026
- Publication type:
- Article
7
A Systematic Review of Clinical Trials of Hormone Therapy on Cognitive Function: Effects of Age at Initiation and Progestin Use.
- Published in:
- Annals of the New York Academy of Sciences, 2005, v. 1052, n. 1, p. 182, doi. 10.1196/annals.1347.012
- By:
- Publication type:
- Article
8
Methodological Issues in Estrogen Treatment Trials for Alzheimer's Disease.
- Published in:
- Annals of the New York Academy of Sciences, 2005, v. 1052, n. 1, p. 173, doi. 10.1196/annals.1347.014
- By:
- Publication type:
- Article
9
Part IV: What Is the Most Appropriate Design for Clinical Trials That Address the Efficacy of Hormone/Estrogen Therapy?
- Published in:
- Annals of the New York Academy of Sciences, 2005, v. 1052, n. 1, p. 171, doi. 10.1196/annals.1347.025
- Publication type:
- Article
10
The Case for Progesterone.
- Published in:
- Annals of the New York Academy of Sciences, 2005, v. 1052, n. 1, p. 152, doi. 10.1196/annals.1347.011
- By:
- Publication type:
- Article
11
Mechanisms of Progesterone-Induced Neuroprotection.
- Published in:
- Annals of the New York Academy of Sciences, 2005, v. 1052, n. 1, p. 145, doi. 10.1196/annals.1347.010
- By:
- Publication type:
- Article
12
Estrogen and the Brain: Beyond ER-α, ER-β, and 17β-Estradiol.
- Published in:
- Annals of the New York Academy of Sciences, 2005, v. 1052, n. 1, p. 136, doi. 10.1196/annals.1347.009
- By:
- Publication type:
- Article
13
Development of 17 α-Estradiol as a Neuroprotective Therapeutic Agent: Rationale and Results from a Phase I Clinical Study.
- Published in:
- Annals of the New York Academy of Sciences, 2005, v. 1052, n. 1, p. 116, doi. 10.1196/annals.1347.008
- By:
- Publication type:
- Article
14
Clinical Pharmacology and Differential Cognitive Efficacy of Estrogen Preparations.
- Published in:
- Annals of the New York Academy of Sciences, 2005, v. 1052, n. 1, p. 93, doi. 10.1196/annals.1347.007
- By:
- Publication type:
- Article
15
Part III: What Are Appropriate Formulations of Hormone/Estrogen Therapy?
- Published in:
- Annals of the New York Academy of Sciences, 2005, v. 1052, n. 1, p. 91, doi. 10.1196/annals.1347.024
- Publication type:
- Article
16
Estrogen: A Neuroprotective or Proinflammatory Hormone?: Emerging Evidence from Reproductive Aging Models.
- Published in:
- Annals of the New York Academy of Sciences, 2005, v. 1052, n. 1, p. 75, doi. 10.1196/annals.1347.006
- By:
- Publication type:
- Article
17
Investigative Models for Determining Hormone Therapy-Induced Outcomes in Brain: Evidence in Support of a Healthy Cell Bias of Estrogen Action.
- Published in:
- Annals of the New York Academy of Sciences, 2005, v. 1052, n. 1, p. 57, doi. 10.1196/annals.1347.005
- By:
- Publication type:
- Article
18
Is the Estrogen Controversy Over?: Deconstructing the Women's Health Initiative Study: A Critical Evaluation of the Evidence.
- Published in:
- Annals of the New York Academy of Sciences, 2005, v. 1052, n. 1, p. 43, doi. 10.1196/annals.1347.004
- By:
- Publication type:
- Article
19
Part II: What Is the Ideal Therapeutic Window for Hormone/Estrogen Therapy?
- Published in:
- Annals of the New York Academy of Sciences, 2005, v. 1052, n. 1, p. 41, doi. 10.1196/annals.1347.023
- Publication type:
- Article
20
Depression, the Perimenopause, and Estrogen Therapy.
- Published in:
- Annals of the New York Academy of Sciences, 2005, v. 1052, n. 1, p. 27, doi. 10.1196/annals.1347.003
- By:
- Publication type:
- Article
21
Menopausal Hot Flashes and Development of Cognitive Impairment.
- Published in:
- Annals of the New York Academy of Sciences, 2005, v. 1052, n. 1, p. 11, doi. 10.1196/annals.1347.002
- By:
- Publication type:
- Article
22
Surgical Menopause, Estrogen, and Cognitive Function in Women: What Do the Findings Tell Us?
- Published in:
- Annals of the New York Academy of Sciences, 2005, v. 1052, n. 1, p. 3, doi. 10.1196/annals.1347.001
- By:
- Publication type:
- Article
23
Part I: What Is the Appropriate Population of Women to Study/Treat When Considering Hormone/Estrogen Therapy?
- Published in:
- Annals of the New York Academy of Sciences, 2005, v. 1052, n. 1, p. 1, doi. 10.1196/annals.1347.022
- Publication type:
- Article
24
Introduction.
- Published in:
- Annals of the New York Academy of Sciences, 2005, v. 1052, n. 1, p. ix, doi. 10.1196/annals.1347.021
- By:
- Publication type:
- Article